
Renal Denervation Catheters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Description
Renal Denervation Catheters Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Summary
Renal denervation, also known as renal sympathetic denervation (RSD), is a minimally invasive, catheter-based endovascular procedure that utilizes radiofrequency energy or ultrasound energy to ablate nerves in the walls of the renal artery, causing a reduction in the nerve activity which ultimately reduces the blood pressure in patients with resistant hypertension. GlobalData's Medical Devices sector report, “Renal Denervation Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Renal Denervation Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
The Renal Denervation Catheters report provides key information and data related to:
Extensive coverage of the Renal Denervation Catheters under development
Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates
Reviews of major players involved in the pipeline product development.
Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and the number of trials of the major Renal Denervation Catheters pipeline products.
Review of Recent Developments in the segment / industry
The Renal Denervation Catheters report enables you to:
Access significant competitor information, analysis, and insights to improve your R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Renal Denervation Catheters under development
Formulate market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
The GlobalData Differentiation
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:
- 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
- 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports
- 64,000+ medical equipment company profiles
- 5,600+ company profiles of medical equipment manufacturers in China and India
- 2,200+ company profiles of medical equipment manufacturers in Japan
- 1,200+ companies’ revenue splits and market shares
- 1,600+ quarterly and annual medical equipment company financials
- 850+ medical equipment company SWOTs
- 28,000+ pipeline product profiles
- 56,400+ marketed product profiles
- 47,000+ clinical trials
- 41,500+ trial investigators
- 7,000+ reports on companies with products in development
- 44,000+ deals in the medical equipment industry
- 1,100+ surgical and diagnostic procedures by therapy area
- 50+ key healthcare indicators by country
- 431,000+ Themes Content Items
- 600+ Influencers
- 1,900+ Analysts & Researchers
- 0.5m+ Community Members
- 141,000+ Macroeconomic Indicators
- 1,013,000+ City Indicators
- Extensive coverage of the Renal Denervation Catheters under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Renal Denervation Catheters and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Renal Denervation Catheters under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Table of Contents
93 Pages
- About GlobalData
- Renal Denervation Catheters Overview
- Renal Denervation Catheters - Pipeline Products by Stage of Development
- Renal Denervation Catheters - Pipeline Products by Segment
- Renal Denervation Catheters - Pipeline Products by Territory
- Renal Denervation Catheters - Pipeline Products by Regulatory Path
- Renal Denervation Catheters - Pipeline Products by Estimated Approval Date
- Renal Denervation Catheters - Ongoing Clinical Trials
- Renal Denervation Catheters Companies - Pipeline Products by Stage of Development
- Renal Denervation Catheters - Companies Pipeline Products by Stage of Development
- Abbott Vascular Inc Company Overview
- Ablative Solutions Inc Company Overview
- Brattea Company Overview
- CryoMedix, LLC. Company Overview
- Handok-Kalos Medical Company Overview
- Johns Hopkins University Company Overview
- Kona Medical Inc Company Overview
- Lepu Medical Technology (Beijing) Co Ltd Company Overview
- Lifetech Scientific (Shenzhen) Co Ltd Company Overview
- Mayo Clinic Company Overview
- Medtronic Plc Company Overview
- MicroPort Scientific Corp Company Overview
- Northwind Medical Inc Company Overview
- ReCor Medical Inc Company Overview
- Renal Dynamics, LLC Company Overview
- Renaly Ltd Company Overview
- Shanghai AngioCare Medical Technology Co Ltd Company Overview
- Shanghai Golden Leaf Medtech Co Ltd Company Overview
- SoniVie Ltd. Company Overview
- Sound Interventions, Inc. Company Overview
- St. Jude Medical LLC Company Overview
- Suzhou Rainmed Medical Technology Co Ltd Company Overview
- Suzhou Xinmai Medical Equipment Co Ltd Company Overview
- Symple Surgical Inc Company Overview
- Tel Aviv University Company Overview
- Terumo Interventional Systems Company Overview
- University of Sydney Company Overview
- Venus Medtech Hangzhou Inc Company Overview
- Verve Medical, Inc. Company Overview
- Oct 26, 2023: Boston Scientific Announces Results for Third Quarter 2023
- Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business
- Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
- Aug 17, 2023: Mayo Clinic Reports Strong Finances for 2023 So Far with Q2 Revenue of $4.47 billion
- Aug 11, 2023: Kristin Peck, CEO of Zoetis, to join Mayo Clinic Board of Trustees
- Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024
- Jul 19, 2023: Boston Scientific lays off 52 workers as it closes another Silicon Valley facility
- Jul 19, 2023: Boston Scientific Lays off 52 Amid California Facility Closure
- Jul 03, 2023: Medtronic Statement on ESH Guidelines for Hypertension and Renal Denervation
- May 16, 2023: PAVmed provides business update and Q1 financial results
- May 15, 2023: Terumo announces consolidated financial results for the fiscal year ended March 31, 2023
- May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
- May 05, 2023: PAVmed to hold a business update conference call and webcast on May 17, 2023
- May 03, 2023: Kalos Medical announces grant award, completion of patient recruitment of clinical trial
- Apr 12, 2023: Medtronic has a layoff in California
- Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
- Mar 14, 2023: PAVmed Provides Business Update and Preliminary Fourth Quarter and Full Year 2022 Financial Results
- Feb 09, 2023: Terumo Notice Concerning Revision of the Full-Year Financial Guidance for Fiscal Year Ending March 31, 2023
- Feb 09, 2023: Terumo Corp Announces Consolidated Financial Results for the Third Quarter Ended December 31, 2022
- Nov 23, 2022: Medtronic Reports Quarterly Earnings
- Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results
- Nov 22, 2022: Mayo Clinic surgeon takes the wheel as Kwik Trip's new CEO
- Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday
- Nov 15, 2022: PAVmed Provides Business Update and Third Quarter 2022 Financial Results
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.